Tandem Diabetes Care Inc.

NASDAQ: TNDM · Real-Time Price · USD
10.83
0.17 (1.59%)
At close: Aug 15, 2025, 3:59 PM
10.82
-0.09%
After-hours: Aug 15, 2025, 04:10 PM EDT

Tandem Diabetes Care Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.12B 1.1B 1.06B 973.67M 796M 770.01M 747.72M 771.42M 790.35M 794.69M 801.22M 790.71M 765.79M 737.67M 702.8M 660.87M 604.84M 541.94M
Cost of Revenue
594.67M 588.96M 569.95M 548.25M 405.49M 390.55M 380.03M 381.51M 385.76M 389.89M 388.23M 379.52M 362.28M 343.65M 326.58M 307.83M 283.23M 258.39M
Gross Profit
526.37M 513.31M 489.57M 425.41M 390.51M 379.45M 367.69M 389.92M 404.59M 404.8M 412.99M 411.19M 403.51M 394.02M 376.21M 353.04M 321.61M 283.55M
Operating Income
-199.36M -178.33M -99.13M -133.6M -139.06M -147.09M -151.88M -134.58M -150.53M -123.96M -92.82M -63.46M -8.24M 9.43M 21.53M 28.58M 19.85M 2.38M
Interest Income
9.86M 12.68M 17.99M 19.04M 19.35M 22.31M 22.86M 20.5M 16.56M 11.54M 6.06M 2.86M 1.18M 830K 721K 1.05M 1.17M 1.16M
Pretax Income
-202.41M -174.43M -91.87M -123.2M -131.31M -136.2M -220.25M -205.06M -221.68M -200M -92.85M -65.59M -12.4M 4.62M 15.9M 21.79M 6.58M -26.67M
Net Income
-205.45M -183.87M -96.03M -126.78M -136.49M -141.45M -222.61M -208.46M -224.47M -203.75M -94.59M -67.93M -13.17M 5.89M 15.57M 21.76M 6.56M -24.56M
Selling & General & Admin
428.93M 413.57M 389.82M 369.74M 349.43M 352.8M 352.5M 364.44M 369.22M 352.22M 335.68M 309.49M 290.31M 276.21M 261.51M 244.53M 229.83M 213.75M
Research & Development
276.86M 278.06M 198.88M 189.28M 180.14M 173.75M 169.67M 162.65M 188.49M 179.13M 170.13M 164.04M 120.33M 107.25M 92.06M 79.94M 71.93M 67.42M
Other Expenses
19.95M n/a n/a n/a 816K 816K 816K 816K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
725.73M 691.64M 588.7M 559.02M 529.57M 526.55M 522.17M 527.09M 557.71M 531.35M 505.81M 473.52M 410.63M 383.47M 353.56M 324.46M 301.76M 281.17M
Interest Expense
8.12M 7.38M 7.42M 7.36M 10.33M 10.14M 9.88M 9.66M 6.39M 5.87M 5.75M 5.73M 5.67M 6.1M 6.09M 9.3M 12.64M 14.36M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
1.32B 1.28B 1.16B 1.11B 935.06M 917.1M 902.2M 908.6M 943.47M 921.25M 894.04M 853.04M 772.91M 727.12M 680.15M 632.29M 585M 539.56M
Income Tax Expense
3.04M 9.44M 4.16M 3.59M 5.18M 5.26M 2.36M 3.4M 2.79M 3.75M 1.74M 2.34M 773K -1.27M 335K 36K 21K -2.12M
Shares Outstanding (Basic)
67.05M 66.4M 65.94M 65.54M 64.99M 65.33M 65.37M 65.12M 64.83M 64.55M 64.38M 64.24M 64.08M 63.88M 63.65M 63.17M 62.72M 62.45M
Shares Outstanding (Diluted)
67.05M 66.4M 66.16M 65.54M 64.99M 65.33M 65.37M 65.12M 64.83M 64.55M 64.38M 64.24M 64.08M 63.88M 65.93M 64.78M 65.66M 62.45M
EPS (Basic)
-3.09 -2.78 -1.46 -1.93 -2.09 -2.17 -3.44 -3.23 -3.48 -3.16 -1.47 -1.05 -0.2 0.09 0.24 0.34 0.10 -0.41
EPS (Diluted)
-3.09 -2.78 -1.46 -1.93 -2.09 -2.17 -3.44 -3.23 -3.48 -3.16 -1.47 -1.06 -0.21 0.08 0.23 0.29 0.05 -0.46
EBITDA
-177.66M -150.68M -67.85M -99.44M -104.77M -109.69M -194.66M -180.07M -200.47M -179.57M -72.73M -45.58M 7.81M 24.54M 36.08M 41.91M 29.27M -3.36M
EBIT
-194.79M -167.56M -85.21M -117.2M -123.04M -128.11M -212.24M -197.16M -216.34M -195.19M -88.04M -60.78M -8.08M 8.94M 20.64M 29.98M 18.54M -12.77M
Depreciation & Amortization
17.13M 16.88M 16.61M 16.39M 16.2M 16.36M 15.71M 15.32M 14.81M 14.1M 14.33M 14.21M 14.1M 13.99M 13.85M 13.75M 13.34M 12.11M